- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
9 Cards in this Set
- Front
- Back
|
GHRH Stimulants
|
Dopamine
Serotonin alpha-adrergic agonists Somatostatin |
|
GHRH Inhibitors
|
beta adrenergic agonists
free fatty acids IGF-1 GH |
|
Somatorelin
|
GHRH analog
|
|
Ghrelin
|
causes GH release
|
|
what increases circulating GH binding proteins
|
Obesity
estrogen |
|
what are the therapy options for GH hypersecretion?
|
tumor irradiation/surgery
dopamine agonists (bromocriptine, cabergolide) somatostatin analogs (octreotide, lanreotide) GH receptor antagnoist (Pegvisomant) |
|
What should be noted before use of dopamine agonists in treatment of GH hypersecretion?
|
Must note health status of patient before use
|
|
What are some cautions of Pegvisomant treatment?
|
Pegvisomant = GH receptor antagonist
should not be used in patient with liver damage (elevated transaminase levels) careful follow up of pituitary by MRI mandatory since interferes with IGF-1 mediated inhibition and can lead to GH-secreting adenomas |
|
what is the consequence of GH hyposecretion in adults?
|
decreased muscle mass
increased fat mass decreased bone mineral density |